Patents by Inventor Zhaobing Ding

Zhaobing Ding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS AND ANTAGONISTS OF HUMAN PYCR1
    Publication number: 20190031773
    Abstract: The present invention is related to an antagonist of PYCR1 for the treatment and/or prevention of a neoplastic disease.
    Type: Application
    Filed: May 23, 2018
    Publication date: January 31, 2019
    Inventors: Sylvia GRÜNEWALD, Michael STECKEL, Manfred HUSEMANN, Hanna MEYER, Weiping HAN, Zhaobing DING
  • METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS
    Publication number: 20160331727
    Abstract: There is presently provided methods for delivering an anti-fibrotic or anti-cancer agent to a cell. The methods comprise contacting a cell with an effective amount of imidazolium and imidazolinium compounds as described herein, including imidazolium and imidazolinium salts.
    Type: Application
    Filed: July 1, 2015
    Publication date: November 17, 2016
    Applicant: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Lang Zhuo, Chunyan Zhang, Yugen Zhang, Jackie Y. Ying, Began Gopalan, Zhiyuan Ke, Zhaobing Ding
  • METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS
    Publication number: 20160000757
    Abstract: There is presently provided methods for delivering an anti-fibrotic or anti-cancer agent to a cell. The methods comprise contacting a cell with an effective amount of imidazolium and imidazolinium compounds as described herein, including imidazolium and imidazolinium salts.
    Type: Application
    Filed: July 1, 2015
    Publication date: January 7, 2016
    Applicant: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Lang Zhuo, Chunyan Zhang, Yugen Zhang, Jackie Y. Ying, Began Gopalan, Zhiyuan Ke, Zhaobing Ding
  • Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds
    Patent number: 9072729
    Abstract: There is presently provided methods for delivering an anti-fibrotic or anti-cancer agent to a cell. The methods comprise contacting a cell with an effective amount of imidazolium and imidazolinium compounds as described herein, including imidazolium and imidazolinium salts.
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: July 7, 2015
    Assignee: Agency for Science, Technology and Research
    Inventors: Lang Zhuo, Chunyan Zhang, Yugen Zhang, Jackie Y. Ying, Began Gopalan, Zhiyuan Ke, Zhaobing Ding
  • PANCREATIC STELLATE CELL SPECIFIC PROMOTER AND USES THEREOF
    Publication number: 20110268711
    Abstract: There is presently provided a method for effecting pancreatic stellate cell-specific gene expression comprising delivering a nucleic acid comprising a glial fibrillary acidic protein promoter operably linked to a coding sequence to a pancreatic stellate cell.
    Type: Application
    Filed: August 21, 2008
    Publication date: November 3, 2011
    Applicant: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Lang Zhuo, Zhaobing Ding
  • METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS
    Publication number: 20110178040
    Abstract: There is presently provided methods for delivering an anti-fibrotic or anti-cancer agent to a cell. The methods comprise contacting a cell with an effective amount of imidazolium and imidazolinium compounds as described herein, including imidazolium and imidazolinium salts.
    Type: Application
    Filed: January 30, 2009
    Publication date: July 21, 2011
    Applicant: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Lang Zhuo, Chunyan Zhang, Yugen Zhang, Jackie Y. Ying, Began Gopalan, Zhiyuan Ke, Zhaobing Ding